AAAAAA
Results:
1-7
|
Results: 7
Authors:
Drapalski, AL
Rosse, RB
Peebles, RR
Schwartz, BL
Marvel, CL
Deutsch, SI
Citation: Al. Drapalski et al., Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medication, CLIN NEUROP, 24(5), 2001, pp. 290-294
Authors:
Deutsch, SI
Rosse, RB
Schwartz, BL
Mastropaolo, J
Citation: Si. Deutsch et al., A revised excitotoxic hypothesis of schizophrenia: Therapeutic implications, CLIN NEUROP, 24(1), 2001, pp. 43-49
Authors:
Rosenberg, PB
Rosse, RB
Schwartz, BL
Deutsch, SI
Citation: Pb. Rosenberg et al., Nefazodone in the adjunctive therapy of schizophrenia: An open-label exploratory study, CLIN NEUROP, 23(4), 2000, pp. 222-225
Authors:
Deutsch, SI
Citation: Si. Deutsch, Specific cognitive deficits in neurologic and psychiatric disease - Targets for treatment, NEUROLOGY, 54(6), 2000, pp. 1215-1217
Authors:
Schwartz, BL
Rosse, RB
Johri, S
Deutsch, SI
Citation: Bl. Schwartz et al., Visual scanning of facial expressions in schizophrenia, J NEUROP CL, 11(1), 1999, pp. 103-106
Authors:
Deutsch, SI
Rosse, RB
Schwartz, BL
Powell, DG
Mastropaolo, J
Citation: Si. Deutsch et al., Stress and a glycinergic intervention interact in the modulation of MK-801-elicited mouse popping behavior, PHARM BIO B, 62(2), 1999, pp. 395-398
Authors:
Deutsch, SI
Mastropaolo, J
Rosse, RB
Citation: Si. Deutsch et al., Neurodevelopmental consequences of early exposure to phencyclidine and related drugs, CLIN NEUROP, 21(6), 1998, pp. 320-332
Risultati:
1-7
|